JavaScript is disabled in your browser. For the best experience, please enable it. All essential information and navigation links remain available below.

Sign in

Homepage
Medications
Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals-H-C-1206-II-0004

Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals-H-C-1206-II-0004

Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals-H-C-1206-II-0004

1 / 1

Pharmaceutical

Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals-H-C-1206-II-0004

Advanced pharmaceutical formulation for targeted therapeutic intervention.

Dosage

-

Strength

-

Pack Size

-

Form

-

Source

European Medicines Agency

View Source

Related Clinical Articles

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

View All Alternatives

Related Medications

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

View All Alternatives

Scan this QR code to access this page quickly on your mobile device.

QR Code